The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

BTOG 2020 | UK excels at molecular testing for lung cancer

Name: UK excels at molecular testing for lung cancer
Uploaded: 2020-01-29T00:00:00Z
Duration: 51 s
Description: Speaking from the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK, Riyaz Shah, FRCP, PhD, The Royal Marsden Hospital, London, UK, discusses the practice of molecular testing for patients with lung cancer in the UK.

Riyaz Shah • 29 Jan 2020

BTOG 2020

Lung Cancer Non-Small Cell Lung Cancer

Speaking from the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK, Riyaz Shah, FRCP, PhD, The Royal Marsden Hospital, London, UK, discusses the practice of molecular testing for patients with lung cancer in the UK.